Akin to siRNA results, inhibition of DYRK1A using its specific inhibitor harmine22 also led to decrease in the cellular proliferation of majority of the HNSCC cells (Supplementary Fig. 2). This evidence concerns the gene DYRK1A and head and neck squamous cell carcinoma.